Literature DB >> 23305473

Diagnosis of BPH and treatment of LUTS among GPs: a European survey.

F Montorsi1, D Mercadante.   

Abstract

AIMS OF THE STUDY: This survey was conducted in France, Germany, Italy, Spain and UK, with the aim to assess diagnosis and therapy of BPH patients in clinical practice. METHODS USED TO CONDUCT THE STUDY: A selected cohort of 455 general practitioners (GPs) in Europe were asked to report information on BPH patients with lower urinary tract symptoms (LUTS), including patient characteristics, diagnostic procedures, severity of illness, symptoms duration and underlying conditions. The GPs provided data relating to 886 patients. RESULTS OF THE STUDY: The diagnostic work-up included description of symptoms (74.9-85.1%), rectal examination (55.4-82.1%) and the determination of PSA (79.1-94.7%). Transrectal sonography was popular in Italy and France (51.1% and 55.9%, respectively), less so in Germany (15.3%) and Spain (13.1%) and not at all in the UK (2.3%). At diagnosis, the most common symptom was nocturia (71-88%), followed by frequency (15-79%), urgency (43-68%) and weak stream (47-64%). The most common combination was the triad nocturia-frequency-feeling of incomplete emptying (22-31%). The mean ± SD LUTS severity score was similar in all countries: The main aim of treatment was the resolution of nocturia, which had an average score that reflected an important need (> 3.5) closely followed by frequency (3.3-3.9). CONCLUSIONS DRAWN FROM THE STUDY AND CLINICAL IMPLICATIONS: This survey has shown that the most common LUTS is nocturia. Analyses of the symptoms' pattern revealed that the most common combination appears to be the triad nocturia-frequency-feeling of incomplete emptying. An association between LUTS and heart disease, diabetes and hypertension suggests that the pharmacological treatment should be devoid of effects on the cardiovascular system. With alpha blockers as first line treatment of LUTS, respondents were more concerned with hypotensive episodes resulting in falls, rather than about other typical side effects (e.g. ejaculation disorders and lowered libido). The survey highlights educational needs in diagnostics.
© 2013 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23305473     DOI: 10.1111/j.1742-1241.2012.03012.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  12 in total

Review 1.  The evaluation and treatment of prostate-related LUTS in the primary care setting: the next STEP.

Authors:  Matt T Rosenberg; David Staskin; John Riley; Grannum Sant; Martin Miner
Journal:  Curr Urol Rep       Date:  2013-12       Impact factor: 3.092

2.  The impact of adding low-dose oral desmopressin therapy to tamsulosin therapy for treatment of nocturia owing to benign prostatic hyperplasia.

Authors:  Abul-Fotouh Ahmed; Aref Maarouf; Essam Shalaby; Ahmad H Gabr; Ashraf Shahin; Ammar Ghobish
Journal:  World J Urol       Date:  2014-08-20       Impact factor: 4.226

3.  Open-label, 9-month extension study investigating the uro-selective alpha-blocker silodosin in men with LUTS associated with BPH.

Authors:  Nadir I Osman; Christopher R Chapple; Teuvo L Tammela; Andreas Eisenhardt; Matthias Oelke
Journal:  World J Urol       Date:  2015-02-25       Impact factor: 4.226

4.  The Effectiveness of Silodosin for Nocturnal Polyuria in Elderly Men With Benign Prostatic Hyperplasia: A Multicenter Study.

Authors:  Young Won Kim; Jinsung Park; Hong Chung; Hong-Wook Kim; Hyung Joon Kim; Jae Hung Jung; Won Tae Kim
Journal:  Int Neurourol J       Date:  2015-09-22       Impact factor: 2.835

5.  Diagnosis and treatment patterns of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia in Murjani General Hospital, Central Kalimantan, Indonesia.

Authors:  Robert Adrianto Raharjo
Journal:  Prostate Int       Date:  2016-02-21

6.  The remote effects of intravitreal anti-VEGF therapy.

Authors:  F Balta; M Merticariu; C Taban; G Neculau; A Merticariu; D Muresanu; D Badescu; V Jinga
Journal:  J Med Life       Date:  2016 Oct-Dec

7.  Management of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia by general practitioners in Jakarta.

Authors:  Faisal Abdi Matondang; Harrina Erlianti Rahardjo
Journal:  Prostate Int       Date:  2014-06-30

8.  Comparative analysis of benign prostatic hyperplasia management by urologists and nonurologists: a Korean nationwide health insurance database study.

Authors:  Juhyun Park; Young Ju Lee; Jeong Woo Lee; Tag Keun Yoo; Jae Il Chung; Seok-Joong Yun; Jun Hyuk Hong; Seong Il Seo; Sung Yong Cho; Hwancheol Son
Journal:  Korean J Urol       Date:  2015-03-03

Review 9.  α1-Blockers in Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: Is Silodosin Different?

Authors:  Claus G Roehrborn; Francisco Cruz; Ferdinando Fusco
Journal:  Adv Ther       Date:  2016-10-17       Impact factor: 3.845

10.  Practice Patterns in Diagnosis and Treatment of Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia among General Practitioners: Lessons Learnt from a Greek Survey

Authors:  Michael Samarinas; Kyriakos Moysidis; Pigi Perdikaki; Stavros Gravas
Journal:  Balkan Med J       Date:  2018-02-27       Impact factor: 2.021

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.